Acorda Site #182 — Falls Church, Virginia

Acorda Site #182 is a clinical research site located in Falls Church, Virginia, United States 22043.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Acorda Site #182 has participated in 1 clinical trials.

Therapeutic areas: Post-ischemic Stroke.

Sponsors: Acorda Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Falls Church

Browse all research sites in Virginia · View every site in Falls Church

• Inova Fairfax Hospitals
• Inova Health System Foundation / Inova Fairfax Hospital
• Institute of Resch & Educ Inova Fairfax Hospital
• Inova Fairfax Hospital/Inova Heart and Vascular Institute
• Inova Medical Group - Fairfax Hospital
• Inova Fairfax Hospital Department of Surgery
• INOVA Hospital
• Inova Fairfax Hospital/ Heart and Vascular Institute Advanced Lung Disease and Transplant Center
• Inova Fairfax Hospital
• Innova Fairfax Hospital
• Inova Health Systems; Inova Fairfax Hospital
• Virginia Hospital Center - Arlington

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Acorda Site #182?

Acorda Site #182 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Acorda Site #182 conducted?

Acorda Site #182 has 1 clinical trials on record. Their work covers Post-ischemic Stroke.

Is Acorda Site #182 accredited by Crixeo Clinical Trials?

Acorda Site #182 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Acorda Site #182?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.